葡萄甘补充剂是否对成年人血清脂质概况产生有利的影响? 一个系统的审查和元分析
Zhu Haijun1, Zhang Ke2, Zhang Dawei3
1Zibo Central Hospital, Department of Cardiology, Zibo, China.
葡萄甘可显著降低总胆固醇和LDL胆固醇,但对HDL胆固醇或甘油三没有临床益处. 它可以作为治疗失脂症管理的辅助疗法.
科学领域:
- 营养科学 营养科学
- 心血管健康 心血管健康
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 脱脂症是心血管疾病和慢性疾病的主要危险因素.
- 葡萄甘是一种可溶性食纤维,在管理脂质配置文件方面显示出潜在的益处.
研究的目的:
- 综合评估葡萄康南对各种脂质特征参数的影响.
- 为了确定葡萄甘对失脂症的影响的临床意义.
主要方法:
- 在Scopus,PubMed,Embase,Web of Science和谷歌学者中进行系统的文献搜索.
- 包括从研究开始到2024年12月的研究.
- 对脂质参数标准化平均差异 (SMD) 的元分析.
主要成果:
- 总胆固醇 (SMD: -2.26) 和LDL胆固醇 (SMD: -2.57) 的显著降低.
- 没有对HDL胆固醇 (SMD: -0.33) 或甘油三 (SMD: -0.16) 的显著影响.
- 观察到的减少不被认为具有临床意义.
结论:
- 葡萄康南在统计学上显著,但在临床上没有显著的降低总和LDL胆固醇.
- 格鲁科曼南可以被认为是治疗失脂症管理的辅助治疗选择.
- 可能需要进一步的研究来探索最佳剂量和长期临床影响.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Dipeptidyl Peptidase 4 Inhibitors
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Oral Hypoglycemic Agents: Biguanides and Glitazones
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
